HNRNPKP4: A Potential Drug Target and Biomarker (G644063)

Target Name: HNRNPKP4

NCBI ID: G644063

HNRNPKP4

Other Name(s): heterogeneous nuclear ribonucleoprotein K pseudogene 4 | Heterogeneous nuclear ribonucleoprotein K pseudogene 4

HNRNPKP4: A Potential Drug Target and Biomarker

Heterogeneous nuclear ribonucleoprotein (HNRNPKP4) is a protein that is expressed in various tissues throughout the body. It is a key component of the ribosome, which is responsible for the production of proteins in the cell. HNRNPKP4 has been identified as a potential drug target and biomarker due to its unique structure and expression patterns.

HNRNPKP4 is a 22 kDa protein that contains 115 amino acid residues. It has a characteristic HN-type domain, which is a common protein domain that is found in various proteins. The HN-type domain is responsible for the protein's stability and functions as a structural unit. HNRNPKP4 also contains a unique N-terminal region that is rich in electrostatic potentials, which may play a role in the protein's stability and interactions with other proteins.

One of the key features of HNRNPKP4 is its expression patterns. HNRNPKP4 is expressed in various tissues, including muscle, heart, brain, and liver. It is also expressed in the placenta, which may be an important target for a drug that can promote its expression. The expression patterns of HNRNPKP4 may also be related to its function, as changes in the level of expression may indicate changes in cellular processes that are important for the protein's function.

Another potential aspect of HNRNPKP4 is its role in cellular processes. HNRNPKP4 is a component of the ribosome, which is responsible for the production of proteins in the cell. It is possible that changes in the level of HNRNPKP4 expression may affect the rate of protein production in the cell, which could be an important factor in the development of diseases.

In addition to its expression and role in cellular processes, HNRNPKP4 is also of interest as a potential drug target. The HN-type domain and unique N-terminal region of the protein make it a potential target for small molecules. Additionally, the protein's expression patterns in various tissues and its involvement in cellular processes may make it an attractive target for drugs that can modulate cellular processes and improve protein production.

In conclusion, HNRNPKP4 is a protein that has unique characteristics and is expressed in various tissues throughout the body. Its HN-type domain and unique N-terminal region make it a potential target for small molecules. Its expression patterns and involvement in cellular processes also make it a potential biomarker for diseases. Further research is needed to fully understand the role of HNRNPKP4 as a protein and its potential as a drug target.

Protein Name: Heterogeneous Nuclear Ribonucleoprotein K Pseudogene 4

The "HNRNPKP4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HNRNPKP4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets